Centogene N V (CNTG) Gross Profit Margin starting from the fourth quarter 2023 to fourth quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Centogene N v   (NASDAQ: CNTG)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Centogene N V 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CNTG Gross Profit Margin (Dec 31 2023)
Q4 		0
Q3 		0
Q2 		0
Q1 		(Dec 31 2022)
Q4
Y / Y Revenue Change 2.16 %
Seq. Revenue Change -
Revenue In Millions $54.32
Gross Profit Margin 35.57 %
Gross Profit Margin Total Ranking # 2450
Gross Profit In Millions $19.32
Y / Y Gross Profit Change -12.71 %
Seq. Gross Profit Change -


Commenting fourth quarter 2023 Gross Profit Margin



Observing fourth quarter 2023 results within Medical Laboratories industry 23 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 2450.
Learn about Gross Margin
CNTG's Gross Profit Margin fourth quarter 2023 Company Ranking
Within: No.
Medical Laboratories Industry # 24
Healthcare Sector # 408
Overall # 2421

Gross Profit Margin Statistics
High Average Low
41.63 % 30.67 % 14.83 %
(Dec 31 2022)   (Dec 31 2021)


CNTG Gross Income Trends • More of CNTG's Profitabilty Ratios • CNTG Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
CNTG's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CNTG's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CNTG's Competitors
Gross Profit Margin Profit Margin for Centogene N V 's Suppliers
Gross Profit Margin Profit Margin for CNTG's Customers

You may also want to know
CNTG's Annual Growth Rates CNTG's Profitability Ratios CNTG's Asset Turnover Ratio CNTG's Dividend Growth
CNTG's Roe CNTG's Valuation Ratios CNTG's Financial Strength Ratios CNTG's Gross Profit Growth
CNTG's Roa CNTG's Inventory Turnover Ratio CNTG's Growth Rates CNTG's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2023, within Medical Laboratories Industry Gross Profit MarginDec 31 2023 MRQ Gross ProfitDec 31 2023 MRQ Revenue
Bioaffinity Technologies Inc   96.57 %$ 2.137  Millions$ 2.213  Millions
Incyte Corporation  93.12 %$ 943.590  Millions$ 1,013.341  Millions
Maxcyte inc   89.96 %$ 14.092  Millions$ 15.665  Millions
Castle Biosciences Inc   81.21 %$ 53.697  Millions$ 66.120  Millions
Caredx Inc   78.95 %$ 51.764  Millions$ 65.569  Millions
Veracyte Inc   75.45 %$ 74.094  Millions$ 98.199  Millions
Inotiv Inc   71.16 %$ 96.424  Millions$ 135.501  Millions
Exact Sciences Corporation  70.17 %$ 453.921  Millions$ 646.885  Millions
Burning Rock Biotech Limited  67.58 %$ 51.159  Millions$ 75.696  Millions
Nrc Health  63.70 %$ 24.208  Millions$ 38.001  Millions
Mdxhealth Sa  62.58 %$ 43.929  Millions$ 70.193  Millions
Exagen Inc   59.17 %$ 8.145  Millions$ 13.765  Millions
American Shared Hospital Services  58.68 %$ 2.816  Millions$ 4.799  Millions
Hologic Inc  56.02 %$ 567.500  Millions$ 1,013.100  Millions
Natera Inc   51.45 %$ 160.065  Millions$ 311.105  Millions
Ge Healthcare Technologies Inc   48.73 %$ 2,156.000  Millions$ 4,424.000  Millions
Ispecimen inc   44.58 %$ 1.148  Millions$ 2.575  Millions
Charles River Laboratories International inc   44.27 %$ 448.629  Millions$ 1,013.476  Millions
Foxo Technologies Inc   43.64 %$ 0.048  Millions$ 0.110  Millions
Koninklijke Philips Nv  40.99 %$ 8,341.760  Millions$ 20,349.280  Millions
Psychemedics Corporation  38.08 %$ 2.058  Millions$ 5.404  Millions
Iqvia Holdings Inc   35.94 %$ 1,390.000  Millions$ 3,868.000  Millions
Fulgent Genetics Inc   35.60 %$ 25.229  Millions$ 70.872  Millions
Centogene N v   35.57 %$ 19.319  Millions$ 54.319  Millions
Renalytix Plc  32.30 %$ 0.229  Millions$ 0.709  Millions
Quest Diagnostics Inc  32.17 %$ 736.000  Millions$ 2,288.000  Millions
Fortrea Holdings Inc   31.94 %$ 247.700  Millions$ 775.400  Millions
Labcorp Holdings Inc   30.39 %$ 696.800  Millions$ 2,293.200  Millions
Icon Plc  29.56 %$ 2,400.227  Millions$ 8,120.176  Millions
Medpace Holdings Inc   27.45 %$ 136.806  Millions$ 498.401  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.